Introducing Fierce Biotech's 2025 Fierce 15

Fierce Biotech·Sep 22

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Fierce Biotech has announced its 2025 Fierce 15. The announcement is being covered alongside other recent developments in the biotech and healthcare industries, including significant funding deals and regulatory approvals. The specific details and implications of the Fierce 15 announcement itself are not clear from the available information.

Full coverage

340B drug purchases hit at least $100B in 2025, administrator reports

Fierce Healthcare·1d ago

Fierce Healthcare Fundraising Tracker '26: Neko Health banks $700M; Rime secures $24M for voice AI platform

Fierce Healthcare·1d ago

Buoyed by $100M series A, Stipple Bio debuts to advance lead oncology asset into clinic

Fierce Biotech·Apr 6

Ascidian, Lilly ink RNA exon editing pact worth up to $1.9B for genetic kidney diseases

Fierce Biotech·Jun 3

2025's Fiercest Women in Life Sciences

Fierce Pharma·Nov 17

Anthropic acquires stealth AI startup Coefficient Bio in $400M deal: reports

Fierce Biotech·Apr 6

Novo Nordisk wins FDA approval for Wegovy in a pill, introducing first oral GLP-1 option for obesity

Fierce Pharma·Dec 22

Fierce 15 of 2025: A breakdown

Fierce Healthcare·Mar 19

View original report at Fierce Biotech ↗

Fetching the latest headlines…